olaparib and alantolactone

olaparib has been researched along with alantolactone* in 1 studies

Other Studies

1 other study(ies) available for olaparib and alantolactone

Article	Year
Design, synthesis and pharmacological evaluation of new PARP1 inhibitors by merging pharmacophores of olaparib and the natural product alantolactone. European journal of medicinal chemistry, 2022, Oct-05, Volume: 240 Topics: Apoptosis; Biological Products; Cell Line, Tumor; G2 Phase Cell Cycle Checkpoints; Humans; Lactones; Phthalazines; Piperazines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Sesquiterpenes, Eudesmane	2022

Article

Year

Design, synthesis and pharmacological evaluation of new PARP1 inhibitors by merging pharmacophores of olaparib and the natural product alantolactone.

European journal of medicinal chemistry, 2022, Oct-05, Volume: 240

Topics: Apoptosis; Biological Products; Cell Line, Tumor; G2 Phase Cell Cycle Checkpoints; Humans; Lactones; Phthalazines; Piperazines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Sesquiterpenes, Eudesmane

2022